| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 151.04M | — |
| Operating expense | — | — |
| Net income | -17.93M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TXG returned +355.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +299.3% |
| 1 year | +355.4% |
| 5 years | -63.0% |
| All-time high | $197.80 (Apr 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in TXG would be worth today ›No. 10x Genomics, Inc. has not paid a dividend in the past 12 months.
10x Genomics, Inc. stock trades on NASDAQ under the ticker symbol TXG.
10x Genomics, Inc. is part of the Healthcare sector.
10x Genomics, Inc. has a market cap of 8.48B USD, based on the latest quote.
10x Genomics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
